MIT-WPU signs MoU with VLSI society to boost semiconductor startups
'From high-end chip design to technician and manufacturing jobs, this growth will empower our youth and help position India as a global electronics and semiconductor hub by 2047,' said Gupta to over 250 delegates from academia, government, and industry.
The conclave, organised by MIT-WPU's Department of Electrical and Electronics Engineering (DoEEE) with support from the Department of Scientific and Industrial Research (DSIR), and Ministry of Science and Technology provided a vital platform for discussion on India's growing semiconductor ecosystem.
A Memorandum of Understanding (MoU) was signed between MIT-WPU and the VLSI Society of India on the occasion to promote research, innovation, and startup development. 'This collaboration will strengthen the semiconductor startup ecosystem by providing techno-commercial mentorship, industry linkages, and seed funding support,' said Milind Pande, pro vice-chancellor, MIT-WPU.
While delivering his speech, Pannerselvam Madangopal, CEO of MeitY Startup Hub, outlined the government's ongoing efforts to support deep-tech startups. 'A robust support system is in place across ministries, offering mentoring, market access, and funding. The ecosystem is maturing to ensure a higher success rate for semiconductor startups,' he said.
Industry leader H. S. Jatana addressed the global challenges facing the sector, including supply chain issues and talent shortages. He also pointed out the opportunities: 'With the right skills and mindset, today's students can become tomorrow's leaders in this high-impact domain'.
Two expert-led panel discussions were also held during the conclave on the subjects - Talent Pipeline for the Semiconductor Industry, Challenges and Opportunities and Semiconductor Innovation in the Age of AI and Edge Computing. The sessions brought together seasoned professionals from top semiconductor companies to share insights on the evolving landscape of chip design, innovation, and talent development.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
CM expands financial powers of administrative secretaries, HoDs
New Delhi: In a move to accelerate "good governance", chief minister Rekha Gupta has enhanced the financial powers of administrative secretaries and heads of all Delhi govt departments, officials said on Thursday. Tired of too many ads? go ad free now According to CM, administrative secretaries will now be able to directly procure all IT-related items, and undertake repairs, rentals, and maintenance, in addition to purchasing equipment and other related material, without procedural delays. "CM highlighted that this is the first revision in officers' financial powers in nearly six years, with the last amendment made on Aug 7, 2019," CM's office said in a statement, adding that technological progress, rising costs, and the introduction of new welfare-oriented schemes have brought about significant changes in the execution of projects. "To build a 'Developed Delhi' and to ensure that the benefits of govt schemes reach the people promptly, her budget this year has risen to Rs 1 lakh crore, compared to Rs 54,800 crore at the time of the last revision. Therefore, the decision has been taken to make effective use of the allocated budget, prevent unnecessary delays in departmental work, speed up the execution of projects, and ensure their timely completion by increasing the financial powers of senior officers," the statement read. In special cases, Gupta added, administrative secretaries have been granted complete financial powers. These include the appointment of individual consultants, consultancies, professionals, project management units, and other specialists; the procurement, repair, rental, and maintenance of all IT-related items; the hiring of human resources; the purchase of equipment; and the acquisition of new vehicles in place of condemned ones. Tired of too many ads? go ad free now "This change in financial powers has been made to protect public trust and to accelerate Delhi's pace of development. It is our responsibility to ensure that public funds are used at the right time, in the right place, and for the right purpose. This decision will not only strengthen good governance but will also make service delivery to the public more effective and timely, while eliminating delays caused by unnecessary inter-departmental movement of files," she said.
Economic Times
4 hours ago
- Economic Times
Artificial Intelligence Designs Two Potential Antibiotics to Combat Drug-Resistant Gonorrhoea and MRSA
Researchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including gonorrhoea and MRSA. AI predicted efficient molecular structures, which were validated in laboratory tests. This innovative method could revolutionize antibiotic discovery, providing faster, cost-efficient development of treatments against superbugs and addressing one of the most urgent public health threats. Tired of too many ads? Remove Ads Targeting Resistant Superbugs Implications for the Future of Antibiotics Tired of too many ads? Remove Ads Next Steps FAQs: In a groundbreaking development, researchers at the Massachusetts Institute of Technology (MIT) have harnessed artificial intelligence (AI) to design two new innovative antibiotics capable of fighting drug-resistant superbugs, including gonorrhoea and MRSA . The method makes a significant step forward in addressing the growing global threat caused by antimicrobial resistance (AMR), which has been explained by the World Health Organization as one of the most urgent public health challenges of the 21st of the newly developed antibiotics has shown remarkable progress against MRSA (methicillin-resistant Staphylococcus aureus), a dangerous pathogen responsible for severe hospital-acquired infections. MRSA is notorious for evading standard antibiotics, leading to prolonged illnesses and higher mortality second compound concentrates on drug-resistant strains of Neisseria gonorrhoeae, the bacterium responsible for gonorrhoea. Rising cases of antibiotic-resistant gonorrhoea have raised serious concerns about treatment failures and broader public health tests confirmed that both compounds successfully killed the targeted bacteria, even those resistant to multiple existing medications. While these results are preliminary, they provide a strong base for further preclinical and clinical successful use of AI in developing these antibiotics signals a new era in drug discovery. By reducing the time and cost involved with developing new drugs, AI could enhance the response to emerging superbugs and other infectious diseases. This is particularly important as the antibiotic pipeline has slowed in recent years, making healthcare systems vulnerable to resistant say that AI-designed antibiotics are not a complete solution but rather an important tool in the ongoing battle against AMR. Complementary strategies, including proper antibiotic stewardship, infection prevention, and global surveillance, remain crucial to handling the spread of resistant aim to advance the new compounds into further preclinical trials to evaluate their safety, efficacy, and side effects in humans. If successful, these antibiotics could provide new treatment for patients affected by resistant infections and save countless lives globally.A1. Superbugs are bacteria resistant to multiple antibiotics, making infections harder to treat. They pose a serious global health risk.A2. AI analyzed vast chemical data to predict molecular structures likely to combat resistant bacteria effectively.
Time of India
5 hours ago
- Time of India
Artificial Intelligence designs two potential antibiotics to combat drug-Resistant Gonorrhoea and MRSA
In a groundbreaking development, researchers at the Massachusetts Institute of Technology (MIT) have harnessed artificial intelligence (AI) to design two new innovative antibiotics capable of fighting drug-resistant superbugs, including gonorrhoea and MRSA . The method makes a significant step forward in addressing the growing global threat caused by antimicrobial resistance (AMR), which has been explained by the World Health Organization as one of the most urgent public health challenges of the 21st century. Targeting Resistant Superbugs One of the newly developed antibiotics has shown remarkable progress against MRSA (methicillin-resistant Staphylococcus aureus), a dangerous pathogen responsible for severe hospital-acquired infections. MRSA is notorious for evading standard antibiotics, leading to prolonged illnesses and higher mortality rates. The second compound concentrates on drug-resistant strains of Neisseria gonorrhoeae, the bacterium responsible for gonorrhoea. Rising cases of antibiotic-resistant gonorrhoea have raised serious concerns about treatment failures and broader public health risks. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Book Your Daily Profit By 11 AM With This Superclass By Mr. Bala TradeWise Learn More Undo Laboratory tests confirmed that both compounds successfully killed the targeted bacteria, even those resistant to multiple existing medications. While these results are preliminary, they provide a strong base for further preclinical and clinical testing. Implications for the Future of Antibiotics The successful use of AI in developing these antibiotics signals a new era in drug discovery. By reducing the time and cost involved with developing new drugs, AI could enhance the response to emerging superbugs and other infectious diseases. This is particularly important as the antibiotic pipeline has slowed in recent years, making healthcare systems vulnerable to resistant infections. Live Events Experts say that AI-designed antibiotics are not a complete solution but rather an important tool in the ongoing battle against AMR. Complementary strategies, including proper antibiotic stewardship, infection prevention, and global surveillance, remain crucial to handling the spread of resistant bacteria. Next Steps Researchers aim to advance the new compounds into further preclinical trials to evaluate their safety, efficacy, and side effects in humans. If successful, these antibiotics could provide new treatment for patients affected by resistant infections and save countless lives globally. FAQs: Q1. What are superbugs? A1. Superbugs are bacteria resistant to multiple antibiotics, making infections harder to treat. They pose a serious global health risk. Q2. How did AI help in developing these antibiotics? A2. AI analyzed vast chemical data to predict molecular structures likely to combat resistant bacteria effectively.
